Clinical Trial: Dovitinib in Adenoid Cystic Carcinoma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase II Study of TKI258 (Dovitinib) Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma

Brief Summary: The purpose of this phase II study of TKI258 (Dovitinib) in adenoid cystic carcinoma is to evaluate the efficacy of TKI258 (Dovitinib).